Effects of food on a new investigational drug
Part of Mental health clinical trials.
This trial tests a new investigational drug called VK4-116 in healthy volunteers to see how food affects its absorption in the body. Participation may help researchers understand how the drug works and could lead to new treatments for conditions like opioid use disorder, though you would not directly benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult aged 18 to 60.
- Have a body mass index (BMI) between 17 and 36, and weigh at least 110 pounds (50 kg).
- Be willing to use effective birth control (if applicable) and avoid sperm donation or pregnancy during the study.
- Not have used nicotine products (smoking or vaping) in the past 6 months.
- Not have taken any prescription drugs in the last 14 days, or over-the-counter medicines, supplements, or herbal products in the last 7 days.
- Be willing to follow study rules, including avoiding alcohol, caffeine, and certain foods (like grapefruit) before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests two experimental medicines given by IV to healthy men. It checks safety and how the body absorbs and processes the drugs (their “pharmacokinetic” profile).
This study tests whether the medication suvorexant can reduce drug cravings in people with opioid use disorder. You will take either suvorexant or a placebo and have your cravings measured in a safe setting.
This study tests an investigational oral medication called MG001 in healthy people who have recently used oral opioids. It aims to see how the drug affects your body and whether it is safe.
This trial tests how safe certain psychoactive substances are and what effects they have in people who have used opioids in the past but are not currently dependent on them. It aims to gather information that could help future treatment options.
This study tests how eating food changes how your body absorbs a new experimental drug called VV913. Researchers will give you the drug with and without food to see if meals make a difference in how well it works.
This trial tests a new oral medication in healthy adults to see how safe it is and how the body handles it. It's an early-stage study, so participants help determine the right dose for future patients.
Hear when a new Opioid Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.